NCT07755904

BHB-1893 Versus Metoprolol for Symptomatic Obstructive Hypertrophic Cardiomyopathy

RecruitingPHASE3INTERVENTIONAL

Trial Details

Start: 2026-10-31Est. Completion: 2028-10

Enrollment target: 210 participants

Contact

Obstructive Hypertrophic Cardiomyopathy (oHCM)

This study aims to evaluate whether, under a treatment strategy primarily guided by left ventricular ejection fraction (…

Multiple LocationsEst. completion Sep 2026

Friedreich AtaxiaCardiomyopathy, Secondary

The purpose of Study LX2006-03, a multicenter, Phase 2, open-label, randomized, controlled study, is to evaluate the eff…

Tampa, United StatesEst. completion Jun 2032

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.